Carl Zeiss Meditec
€31.30Change from previous close: +0.32%Absolute change: +€0.10
At a glance
- Revenue growth
- +7.82%
- FY to Sep 2025 vs FY to Sep 2024
- Net income growth
- −20.99%
- FY to Sep 2025 vs FY to Sep 2024
- Net margin
- 6.3%
- FY to Sep 2024: 8.7%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Operating cash flow | 16.7 | 144 | 57.2 | 34.8 |
| Investing cash flow | 0.7 | -98.9 | 23.4 | 2.1 |
| Financing cash flow | -16.9 | -50.8 | -71.9 | -36.2 |
| Free cash flow | 16.7 | 67.6 | 97.8 | -5.8 |